CKAP4 and neoplasm: The activation of the DKK1-CKAP4 pathway leads to restraint of the function of cytotoxic T-cells, NKs, M1 and M2 macrophages, and tumoral myeloid cells, having as consequence a suppressive tumor immune microenvironment [12].